Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [18F]FDG PET/CT in Early Triple-Negative Breast Cancer

被引:21
作者
Bouron, Clement [1 ,2 ]
Mathie, Clara [3 ]
Seegers, Valerie [4 ]
Morel, Olivier [1 ]
Jezequel, Pascal [5 ,6 ]
Lasla, Hamza [5 ]
Guillerminet, Camille [1 ,7 ]
Girault, Sylvie [1 ]
Lacombe, Marie [1 ]
Sher, Avigaelle [1 ]
Lacoeuille, Franck [2 ,8 ]
Patsouris, Anne [3 ,9 ]
Testard, Aude [1 ]
机构
[1] ICO Pays Loire, Dept Nucl Med, 15 Rue Andre Boquel, F-49055 Angers, France
[2] Univ Hosp Angers, Dept Nucl Med, 4 Rue Larrey, F-49100 Angers, France
[3] ICO Pays Loire, Dept Med Oncol, 15 Rue Andre Boquel, F-49055 Angers, France
[4] ICO Pays Loire, Res & Stat Dept, 15 Rue Andre Boquel, F-49055 Angers, France
[5] ICO Pays Loire, Om Data Sci Unit, Bd Jacques Monod, F-44805 St Herblain, France
[6] Univ Angers, Univ Nantes, INSERM, UMR 1232,CRCINA,Inst Rech Sante, 8 Quai Moncousu BP 70721, F-44007 Nantes 1, France
[7] ICO Pays Loire, Dept Med Phys, 15 Rue Andre Boquel, F-49055 Angers, France
[8] Univ Nantes & Angers, INSERM, UMR 1232, Equipe 17,CRCINA, F-49055 Angers, France
[9] INSERM, UMR 1232, Equipe 12, F-49055 Angers, France
关键词
TNBC; F-18]FDG PET; CT; prognosis; textural features; TOTAL LESION GLYCOLYSIS; TUMOR-INFILTRATING LYMPHOCYTES; F-18-FDG PET/CT; FDG-PET/CT; NEOADJUVANT CHEMOTHERAPY; FEATURES; HETEROGENEITY; ASSOCIATION; SUBTYPES; SURVIVAL;
D O I
10.3390/cancers14030637
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The aim of this study was to evaluate PET/CT parameters to determine different prognostic groups in TNBC, in order to select patients with a high risk of relapse, for whom therapeutic escalation can be considered. We have demonstrated that the MTV, TLG and entropy of the primary breast lesion could be of interest to predict the prognostic outcome of TNBC patients. (1) Background: triple-negative breast cancer (TNBC) remains a clinical and therapeutic challenge primarily affecting young women with poor prognosis. TNBC is currently treated as a single entity but presents a very diverse profile in terms of prognosis and response to treatment. Positron emission tomography/computed tomography (PET/CT) with F-18-fluorodeoxyglucose ([F-18]FDG) is gaining importance for the staging of breast cancers. TNBCs often show high [F-18]FDG uptake and some studies have suggested a prognostic value for metabolic and volumetric parameters, but no study to our knowledge has examined textural features in TNBC. The objective of this study was to evaluate the association between metabolic, volumetric and textural parameters measured at the initial [F-18]FDG PET/CT and disease-free survival (DFS) and overall survival (OS) in patients with nonmetastatic TBNC. (2) Methods: all consecutive nonmetastatic TNBC patients who underwent a [F-18]FDG PET/CT examination upon diagnosis between 2012 and 2018 were retrospectively included. The metabolic and volumetric parameters (SUVmax, SUVmean, SUVpeak, MTV, and TLG) and the textural features (entropy, homogeneity, SRE, LRE, LGZE, and HGZE) of the primary tumor were collected. (3) Results: 111 patients were enrolled (median follow-up: 53.6 months). In the univariate analysis, high TLG, MTV and entropy values of the primary tumor were associated with lower DFS (p = 0.008, p = 0.006 and p = 0.025, respectively) and lower OS (p = 0.002, p = 0.001 and p = 0.046, respectively). The discriminating thresholds for two-year DFS were calculated as 7.5 for MTV, 55.8 for TLG and 2.6 for entropy. The discriminating thresholds for two-year OS were calculated as 9.3 for MTV, 57.4 for TLG and 2.67 for entropy. In the multivariate analysis, lymph node involvement in PET/CT was associated with lower DFS (p = 0.036), and the high MTV of the primary tumor was correlated with lower OS (p = 0.014). (4) Conclusions: textural features associated with metabolic and volumetric parameters of baseline [F-18]FDG PET/CT have a prognostic value for identifying high-relapse-risk groups in early TNBC patients.
引用
收藏
页数:21
相关论文
共 81 条
[1]   Correlation of Maximum Standardized Uptake Values in 18F-Fluorodeoxyglucose Positron Emission Tomography-computed Tomography Scan with Immunohistochemistry and Other Prognostic Factors in Breast Cancer [J].
Abubakar, Zakir Ali ;
Akepati, Naveen Kumar Reddy ;
Bikkina, Prathyusha .
INDIAN JOURNAL OF NUCLEAR MEDICINE, 2019, 34 (01) :10-13
[2]   Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters [J].
Aktas, Gul Ege ;
Tastekin, Ebru ;
Sarikaya, Ali .
NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (01) :83-93
[3]   PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy [J].
Antunovic, Lidija ;
De Sanctis, Rita ;
Cozzi, Luca ;
Kirienko, Margarita ;
Sagona, Andrea ;
Torrisi, Rosalba ;
Tinterri, Corrado ;
Santoro, Armando ;
Chiti, Arturo ;
Zelic, Renata ;
Sollini, Martina .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) :1468-1477
[4]   Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer [J].
Arslan, Esra ;
Cermik, Tevfik F. ;
Trabulus, Fadime D. C. ;
Talu, Esra C. K. ;
Basaran, Serife .
NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (07) :680-690
[5]   Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer [J].
Bundschuh, Ralph A. ;
Dinges, Julia ;
Neumann, Larissa ;
Seyfried, Martin ;
Zsoter, Norbert ;
Papp, Laszlo ;
Rosenberg, Robert ;
Becker, Karen ;
Astner, Sabrina T. ;
Henninger, Martin ;
Herrmann, Ken ;
Ziegler, Sibylle I. ;
Schwaiger, Markus ;
Essler, Markus .
JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (06) :891-897
[6]   Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer [J].
Burstein, Matthew D. ;
Tsimelzon, Anna ;
Poage, Graham M. ;
Coyington, Kyle R. ;
Contreras, Alejandro ;
Fuqua, Suzanne A. W. ;
Sayage, Michelle I. ;
Osborne, C. Kent ;
Hilsenbeck, Susan G. ;
Chang, Jenny C. ;
Mills, Gordon B. ;
Lau, Ching C. ;
Brown, Powel H. .
CLINICAL CANCER RESEARCH, 2015, 21 (07) :1688-1698
[7]  
Buvat I., 2007, Medecine Nucleaire, V21, P165, DOI [10.1016/j.mednuc.2007.03.003, DOI 10.1016/J.MEDNUC.2007.03.003]
[8]   The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes [J].
Carey, Lisa A. ;
Dees, E. Claire ;
Sawyer, Lynda ;
Gatti, Lisa ;
Moore, Dominic T. ;
Collichio, Frances ;
Ollila, David W. ;
Sartor, Carolyn I. ;
Graham, Mark L. ;
Perou, Charles M. .
CLINICAL CANCER RESEARCH, 2007, 13 (08) :2329-2334
[9]   Tumor Heterogeneity Measured on F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Combined With Plasma Epstein-Barr Virus Load Predicts Prognosis in Patients With Primary Nasopharyngeal Carcinoma [J].
Chan, Sheng-Chieh ;
Chang, Kai-Ping ;
Fang, Yu-Hua Dean ;
Tsang, Ngan-Ming ;
Ng, Shu-Hang ;
Hsu, Cheng-Lung ;
Liao, Chun-Ta ;
Yen, Tzu-Chen .
LARYNGOSCOPE, 2017, 127 (01) :E22-E28
[10]   Prognostic Significance of Metabolic Parameters and Textural Features on 18F-FDG PET/CT in Invasive Ductal Carcinoma of Breast [J].
Chang, Chin-Chuan ;
Chen, Chao-Jung ;
Hsu, Wen-Ling ;
Chang, Shu-Min ;
Huang, Ying-Fong ;
Tyan, Yu-Chang .
SCIENTIFIC REPORTS, 2019, 9 (1)